IGF2BP3 and Ewing sarcoma: Interestingly, in Ewing sarcoma cell lines, IGF2BP3-mediated IGF1R loss is compensated by the activation of an IR-A/IGF2 autocrine loop [81], which determines higher sensitivity to the dual IGF1R/IR inhibitor OSI-906 [81].